Preclinical antitumor activity of XK469 (NSC 656889).
LoRusso PM, Parchment R, Demchik L, Knight J, Polin L, Dzubow J, Behrens C, Harrison B, Trainor G, Corbett TH.
LoRusso PM, et al. Among authors: parchment r.
Invest New Drugs. 1998-1999;16(4):287-96. doi: 10.1023/a:1006206814025.
Invest New Drugs. 1998.
PMID: 10426660